Comparison | Outcome: PDNV vs. no PDNV | |
---|---|---|
AOR (95% CI) | p value | |
Patient characteristics | ||
Age (per 1 year increase) | 0.99 (0.98, 1) | 0.002 |
Male sex | 0.63 (0.51, 0.76) | < 0.001 |
ASA | ||
2 vs 1 | 0.99 (0.77, 1.27) | 0.945 |
3 vs 1 | 1.02 (0.69, 1.49) | 0.935 |
3 vs 2 | 1.02 (0.75, 1.4) | 0.876 |
Body mass index (per 1 kg/m2 increase) | 0.98 (0.96, 0.99) | 0.012 |
Current smoker | 0.74 (0.51, 1.08) | 0.115 |
Otolaryngology service ( vs. ophthalmology) | 0.87 (0.66, 1.14) | 0.319 |
Pre/intraoperative anesthesia characteristics | ||
Total anesthesia time (per 1 min increase) | 1 (1, 1) | 0.276 |
Inhalational time (per 1 min increase) | 1 (1, 1) | 0.77 |
Nitrous time (per 1 min increase) | 1 (1, 1) | 0.839 |
Propofol-only TIVA | 0.62 (0.41, 0.94) | 0.025 |
Pre/intraoperative/PACU anesthesia characteristics | ||
PACU phase 1 time (per 1 min increase) | 1 (1, 1) | 0.938 |
PACU phase 2 time (per 1 min increase) | 1 (1, 1) | < 0.001 |
Number of antiemetics used | ||
1 vs. 0 | 0.84 (0.35, 1.98) | 0.683 |
2 vs. 0 | 0.88 (0.38, 2.01) | 0.757 |
3 vs. 0 | 0.67 (0.28, 1.59) | 0.363 |
4 vs. 0 | 0.2 (0.05, 0.84) | 0.028 |
Opioid use (per 1 MME increase) | 1.01 (1, 1.01) | < 0.001 |
PONV | 2.79 (2.24, 3.46) | < 0.001 |